Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Head and Neck Cancer
Interventions
PROCEDURE

Barium Swallow

Participants receive modified barium swallow at baseline and after 8 weeks of using the EMST device

BEHAVIORAL

Questionnaires

Questionnaires completed about symptoms and quality of life at baseline, after 8 weeks of using the EMST device, and 12 months after completing the study.

DEVICE

Expiratory Muscle Strength Training (EMST) Device

Participant uses the EMST device at home on a 5-5-5 schedule (5 repetitions, 5 sets, 5 days per week) for 8 weeks.

DEVICE

Digital Manometer

Digital manometer used to test how forcefully participant is able to exhale and cough at baseline, and one time each week for 8 weeks while using the EMST device.

BEHAVIORAL

Neurocognitive Exams

Participants given neurocognitive exams at baseline.

DRUG

Barium

Participants receive barium prior to modified barium swallow at baseline and after 8 weeks of using the EMST device.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

IRG

UNKNOWN

lead

M.D. Anderson Cancer Center

OTHER

NCT02662907 - Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy | Biotech Hunter | Biotech Hunter